Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 11 studies | 26% ± 8% | |
intestine | 9 studies | 24% ± 10% | |
peripheral blood | 7 studies | 21% ± 4% | |
kidney | 5 studies | 19% ± 4% | |
liver | 5 studies | 18% ± 5% | |
pancreas | 4 studies | 39% ± 19% | |
placenta | 3 studies | 39% ± 12% | |
bone marrow | 3 studies | 23% ± 6% | |
uterus | 3 studies | 34% ± 16% | |
prostate | 3 studies | 29% ± 6% | |
brain | 3 studies | 22% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 3078.74 | 328 / 328 | 100% | 115.67 | 178 / 178 |
prostate | 100% | 2768.42 | 245 / 245 | 100% | 161.44 | 502 / 502 |
stomach | 100% | 2494.82 | 359 / 359 | 100% | 102.75 | 286 / 286 |
bladder | 100% | 2736.14 | 21 / 21 | 100% | 144.43 | 503 / 504 |
uterus | 100% | 2268.88 | 170 / 170 | 100% | 142.61 | 458 / 459 |
ovary | 100% | 1800.47 | 180 / 180 | 100% | 96.57 | 429 / 430 |
intestine | 100% | 2159.72 | 965 / 966 | 100% | 121.87 | 526 / 527 |
thymus | 100% | 6827.23 | 653 / 653 | 100% | 140.78 | 603 / 605 |
breast | 100% | 2130.58 | 459 / 459 | 99% | 111.97 | 1110 / 1118 |
lung | 100% | 3167.59 | 576 / 578 | 99% | 111.05 | 1148 / 1155 |
esophagus | 100% | 2140.17 | 1443 / 1445 | 99% | 62.63 | 181 / 183 |
kidney | 100% | 2673.33 | 89 / 89 | 99% | 59.68 | 888 / 901 |
skin | 100% | 3241.01 | 1809 / 1809 | 99% | 108.53 | 465 / 472 |
liver | 98% | 4570.91 | 222 / 226 | 100% | 127.90 | 406 / 406 |
adrenal gland | 100% | 2309.48 | 258 / 258 | 95% | 71.17 | 218 / 230 |
brain | 91% | 976.06 | 2406 / 2642 | 99% | 62.73 | 696 / 705 |
lymph node | 0% | 0 | 0 / 0 | 100% | 139.03 | 29 / 29 |
spleen | 100% | 3806.23 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 90.94 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 133.46 | 1 / 1 |
blood vessel | 100% | 2817.20 | 1332 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 2164.46 | 1201 / 1204 | 0% | 0 | 0 / 0 |
heart | 97% | 2095.07 | 831 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 92% | 1973.77 | 852 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 88% | 31.19 | 70 / 80 |
muscle | 42% | 332.68 | 337 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007165 | Biological process | signal transduction |
GO_0002014 | Biological process | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure |
GO_0006986 | Biological process | response to unfolded protein |
GO_0031175 | Biological process | neuron projection development |
GO_0071542 | Biological process | dopaminergic neuron differentiation |
GO_1905897 | Biological process | regulation of response to endoplasmic reticulum stress |
GO_0005615 | Cellular component | extracellular space |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005576 | Cellular component | extracellular region |
GO_0033018 | Cellular component | sarcoplasmic reticulum lumen |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0120146 | Molecular function | sulfatide binding |
GO_0008083 | Molecular function | growth factor activity |
GO_0003723 | Molecular function | RNA binding |
Gene name | MANF |
Protein name | Mesencephalic astrocyte-derived neurotrophic factor (Arginine-rich protein) (Protein ARMET) Mesencephalic astrocyte derived neurotrophic factor |
Synonyms | ARMET ARP |
Description | FUNCTION: Selectively promotes the survival of dopaminergic neurons of the ventral mid-brain . Modulates GABAergic transmission to the dopaminergic neurons of the substantia nigra (By similarity). Enhances spontaneous, as well as evoked, GABAergic inhibitory postsynaptic currents in dopaminergic neurons (By similarity). Inhibits cell proliferation and endoplasmic reticulum (ER) stress-induced cell death . Retained in the ER/sarcoplasmic reticulum (SR) through association with the endoplasmic reticulum chaperone protein HSPA5 under normal conditions . Up-regulated and secreted by the ER/SR in response to ER stress and hypoxia . Following secretion by the ER/SR, directly binds to 3-O-sulfogalactosylceramide, a lipid sulfatide in the outer cell membrane of target cells . Sulfatide binding promotes its cellular uptake by endocytosis, and is required for its role in alleviating ER stress and cell toxicity under hypoxic and ER stress conditions . . |
Accessions | ENST00000446668.5 H7C2D6 P55145 ENST00000528157.7 |